# Lineage Cell Therapeutics, Inc.: Form 8-K, filed Nov 20, 2024

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2024-11-20
- Accepted by EDGAR: Nov 20, 2024, 17:08 ET
- Period: 2024-11-19
- Accession: 0000950170-24-129402
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000095017024129402/lctx-20241119.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000095017024129402/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000095017024129402/lctx-20241119.htm

Filed Nov 20, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-129402. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.